$8.98
0.414.78%
At Close: -
$8.93
-0.05-0.56%
After Hours: Aug 23, 5:59 PM EDT
15 minutes delayed
Travere Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Travere Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.65 | $-0.86 | 24.4 % |
Mar 2024 | 2024-05-06 | $-1.51 | $-0.99 | -52.5 % |
Dec 2023 | 2024-02-15 | $-0.94 | $-1.26 | 25.4 % |
Jun 2023 | 2023-08-03 | $-0.77 | $-1.16 | 33.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $52.18M | $50.17M | 4.00 % |
Mar 2024 | 2024-05-06 | $41.37M | $42.85M | -3.44 % |
Dec 2023 | 2024-02-15 | $45.06M | $41.51M | 8.55 % |
Jun 2023 | 2023-08-03 | $59.70M | $53.93M | 10.7 % |
Travere Therapeutics (TVTX) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.65, which beat the estimate of $-0.86.
The Actual Revenue was $52.2M, which beat the estimate of $50.2M.
Browse earnings estimates, EPS, and revenue on all stocks.